Click for best price
Synthetic Lethalitybased Drugs Targets Market Size, Share 2022
In cancers, where mutations have led to the loss of function of one gene, using a drug molecule that specifically targets the corresponding gene of the synlet pair has been demonstrated to be a viable and effective therapeutic regimen. Recent advances in biomarker research, including the development of companion diagnostics, in combination with modern molecular screening platforms, which include clustered regularly interspaced short palindromic repeats (CRISPR)- and RNA interference (RNAi)-based screening techniques, have led to the identification of a number of synthetically lethal gene pairs.
This report contains market size and forecasts of Synthetic Lethality-based Drugs and Targets in Global, including the following market information:
Global Synthetic Lethality-based Drugs and Targets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Synthetic Lethality-based Drugs and Targets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Synthetic Lethality-based Drugs and Targets include AbbVie, AstraZeneca, BeiGene, Clovis Oncology, GlaxoSmithKline, Pfizer, AtlasMedx, Chordia Therapeutics and IDEAYA Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Synthetic Lethality-based Drugs and Targets companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Synthetic Lethality-based Drugs and Targets Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Synthetic Lethality-based Drugs and Targets Market Segment Percentages, by Type, 2021 (%)
Monotherapy
Combination Therapy
Global Synthetic Lethality-based Drugs and Targets Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Synthetic Lethality-based Drugs and Targets Market Segment Percentages, by Application, 2021 (%)
Medical Research Institution
Hospital and Clinic
Other
Global Synthetic Lethality-based Drugs and Targets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Synthetic Lethality-based Drugs and Targets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Synthetic Lethality-based Drugs and Targets revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Synthetic Lethality-based Drugs and Targets revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
AstraZeneca
BeiGene
Clovis Oncology
GlaxoSmithKline
Pfizer
AtlasMedx
Chordia Therapeutics
IDEAYA Biosciences
Mission Therapeutics
Repare Therapeutics
Sierra Oncology
SyntheX Labs
| Report Attributes |
Report Details |
| Report Title |
Synthetic Lethality-based Drugs and Targets Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Synthetic Lethality-based Drugs and Targets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Synthetic Lethality-based Drugs and Targets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Synthetic Lethality-based Drugs and Targets Overall Market Size
2.1 Global Synthetic Lethality-based Drugs and Targets Market Size: 2021 VS 2028
2.2 Global Synthetic Lethality-based Drugs and Targets Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Synthetic Lethality-based Drugs and Targets Players in Global Market
3.2 Top Global Synthetic Lethality-based Drugs and Targets Companies Ranked by Revenue
3.3 Global Synthetic Lethality-based Drugs and Targets Revenue by Companies
3.4 Top 3 and Top 5 Synthetic Lethality-based Drugs and Targets Companies in Global Market, by Revenue in 2021
3.5 Global Companies Synthetic Lethality-based Drugs and Targets Product Type
3.6 Tier 1, Tier 2 and Tier 3 Synthetic Lethality-based Drugs and Targets Players in Global Market
3.6.1 List of Global Tier 1 Synthetic Lethality-based Drugs and Targets Companies
3.6.2 List of Global Tier 2 and Tier 3 Synthetic Lethality-based Drugs and Targets Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Synthetic Lethality-based Drugs and Targets Market Size Markets, 2021 & 2028
4.1.2 Monotherapy
4.1.3 Combination Therapy
4.2 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts
4.2.1 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue, 2017-2022
4.2.2 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue, 2023-2028
4.2.3 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Synthetic Lethality-based Drugs and Targets Market Size, 2021 & 2028
5.1.2 Medical Research Institution
5.1.3 Hospital and Clinic
5.1.4 Other
5.2 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts
5.2.1 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue, 2017-2022
5.2.2 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue, 2023-2028
5.2.3 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Synthetic Lethality-based Drugs and Targets Market Size, 2021 & 2028
6.2 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts
6.2.1 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue, 2017-2022
6.2.2 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue, 2023-2028
6.2.3 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Synthetic Lethality-based Drugs and Targets Revenue, 2017-2028
6.3.2 US Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.3.3 Canada Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.3.4 Mexico Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue, 2017-2028
6.4.2 Germany Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.4.3 France Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.4.4 U.K. Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.4.5 Italy Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.4.6 Russia Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.4.7 Nordic Countries Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.4.8 Benelux Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue, 2017-2028
6.5.2 China Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.5.3 Japan Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.5.4 South Korea Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.5.5 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.5.6 India Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Synthetic Lethality-based Drugs and Targets Revenue, 2017-2028
6.6.2 Brazil Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.6.3 Argentina Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue, 2017-2028
6.7.2 Turkey Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.7.3 Israel Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.7.4 Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
6.7.5 UAE Synthetic Lethality-based Drugs and Targets Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.1.4 AbbVie Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.2.4 AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.2.5 AstraZeneca Key News
7.3 BeiGene
7.3.1 BeiGene Corporate Summary
7.3.2 BeiGene Business Overview
7.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.3.4 BeiGene Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.3.5 BeiGene Key News
7.4 Clovis Oncology
7.4.1 Clovis Oncology Corporate Summary
7.4.2 Clovis Oncology Business Overview
7.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.4.4 Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.4.5 Clovis Oncology Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.5.4 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithKline Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.6.4 Pfizer Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 AtlasMedx
7.7.1 AtlasMedx Corporate Summary
7.7.2 AtlasMedx Business Overview
7.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.7.4 AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.7.5 AtlasMedx Key News
7.8 Chordia Therapeutics
7.8.1 Chordia Therapeutics Corporate Summary
7.8.2 Chordia Therapeutics Business Overview
7.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.8.4 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.8.5 Chordia Therapeutics Key News
7.9 IDEAYA Biosciences
7.9.1 IDEAYA Biosciences Corporate Summary
7.9.2 IDEAYA Biosciences Business Overview
7.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.9.4 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.9.5 IDEAYA Biosciences Key News
7.10 Mission Therapeutics
7.10.1 Mission Therapeutics Corporate Summary
7.10.2 Mission Therapeutics Business Overview
7.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.10.4 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.10.5 Mission Therapeutics Key News
7.11 Repare Therapeutics
7.11.1 Repare Therapeutics Corporate Summary
7.11.2 Repare Therapeutics Business Overview
7.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.11.4 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.11.5 Repare Therapeutics Key News
7.12 Sierra Oncology
7.12.1 Sierra Oncology Corporate Summary
7.12.2 Sierra Oncology Business Overview
7.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.12.4 Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.12.5 Sierra Oncology Key News
7.13 SyntheX Labs
7.13.1 SyntheX Labs Corporate Summary
7.13.2 SyntheX Labs Business Overview
7.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.13.4 SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2017-2022)
7.13.5 SyntheX Labs Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Synthetic Lethality-based Drugs and Targets Market Opportunities & Trends in Global Market
Table 2. Synthetic Lethality-based Drugs and Targets Market Drivers in Global Market
Table 3. Synthetic Lethality-based Drugs and Targets Market Restraints in Global Market
Table 4. Key Players of Synthetic Lethality-based Drugs and Targets in Global Market
Table 5. Top Synthetic Lethality-based Drugs and Targets Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Synthetic Lethality-based Drugs and Targets Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Companies, 2017-2022
Table 8. Global Companies Synthetic Lethality-based Drugs and Targets Product Type
Table 9. List of Global Tier 1 Synthetic Lethality-based Drugs and Targets Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Synthetic Lethality-based Drugs and Targets Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Synthetic Lethality-based Drugs and Targets Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Synthetic Lethality-based Drugs and Targets Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Synthetic Lethality-based Drugs and Targets Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Synthetic Lethality-based Drugs and Targets Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Synthetic Lethality-based Drugs and Targets Product Offerings
Table 32. AbbVie Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Synthetic Lethality-based Drugs and Targets Product Offerings
Table 35. AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 36. BeiGene Corporate Summary
Table 37. BeiGene Synthetic Lethality-based Drugs and Targets Product Offerings
Table 38. BeiGene Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 39. Clovis Oncology Corporate Summary
Table 40. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product Offerings
Table 41. Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product Offerings
Table 44. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Synthetic Lethality-based Drugs and Targets Product Offerings
Table 47. Pfizer Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 48. AtlasMedx Corporate Summary
Table 49. AtlasMedx Synthetic Lethality-based Drugs and Targets Product Offerings
Table 50. AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 51. Chordia Therapeutics Corporate Summary
Table 52. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product Offerings
Table 53. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 54. IDEAYA Biosciences Corporate Summary
Table 55. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product Offerings
Table 56. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 57. Mission Therapeutics Corporate Summary
Table 58. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product Offerings
Table 59. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 60. Repare Therapeutics Corporate Summary
Table 61. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product Offerings
Table 62. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 63. Sierra Oncology Corporate Summary
Table 64. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product Offerings
Table 65. Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
Table 66. SyntheX Labs Corporate Summary
Table 67. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product Offerings
Table 68. SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Synthetic Lethality-based Drugs and Targets Segment by Type in 2021
Figure 2. Synthetic Lethality-based Drugs and Targets Segment by Application in 2021
Figure 3. Global Synthetic Lethality-based Drugs and Targets Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Synthetic Lethality-based Drugs and Targets Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Synthetic Lethality-based Drugs and Targets Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2021
Figure 8. By Type - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
Figure 9. By Application - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
Figure 10. By Region - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
Figure 11. By Country - North America Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
Figure 12. US Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
Figure 16. Germany Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 17. France Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
Figure 24. China Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 28. India Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
Figure 30. Brazil Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2017-2028
Figure 33. Turkey Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BeiGene Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
